Nuclear localization of ataxin-3 is required for the manifestation of symptoms in SCA3: in vivo evidence.
Bichelmeier U, Schmidt T, Hübener J, Boy J, Rüttiger L, Häbig K, Poths S, Bonin M, Knipper M, Schmidt WJ, Wilbertz J, Wolburg H, Laccone F, Riess O.
Bichelmeier U, et al. Among authors: habig k.
J Neurosci. 2007 Jul 11;27(28):7418-28. doi: 10.1523/JNEUROSCI.4540-06.2007.
J Neurosci. 2007.
PMID: 17626202
Free PMC article.